Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
3.2M
-
Number of holders
-
74
-
Total 13F shares, excl. options
-
2.54M
-
Shares change
-
-366K
-
Total reported value, excl. options
-
$216M
-
Value change
-
-$31.3M
-
Number of buys
-
25
-
Number of sells
-
-35
-
Price
-
$85.31
Significant Holders of UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD) as of Q3 2022
79 filings reported holding UTMD - UTAH MEDICAL PRODUCTS INC - Common Shares as of Q3 2022.
UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD) has 74 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.54M shares
of 3.2M outstanding shares and own 79.13% of the company stock.
Largest 10 shareholders include FMR LLC (381K shares), T. Rowe Price Investment Management, Inc. (342K shares), RENAISSANCE TECHNOLOGIES LLC (217K shares), BlackRock Inc. (199K shares), VANGUARD GROUP INC (167K shares), DIMENSIONAL FUND ADVISORS LP (153K shares), RICE HALL JAMES & ASSOCIATES, LLC (118K shares), JPMORGAN CHASE & CO (92.4K shares), HealthInvest Partners AB (86K shares), and Ranger Investment Management, L.P. (73.6K shares).
This table shows the top 74 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.